MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
ENDRA Life Sciences ROCE Ratio 2011-2025 | NDRA
Annual ROCE Ratio ENDRA Life Sciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -281.17 | -179.81 | -173.8 | -106.62 | -147.87 | -212.47 | -139.74 | -87.69 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -87.69 | -281.17 | -166.15 |
Quarterly ROCE Ratio ENDRA Life Sciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -232.5 | -139.26 | -105.48 | -121.41 | -154.46 | -212.05 | -187.51 | -57.59 | -91.08 | -66.98 | -93.77 | -91.76 | -111.91 | -98.57 | -93.13 | -55.7 | -97.46 | -119.06 | -134.71 | -120.12 | -171.86 | -181.85 | -190.41 | -151.13 | -188.83 | -174.79 | -158.41 | -112.29 | -129.56 | -109.13 | -99.98 | -44.14 | 23.57 | 108.54 | 183.88 | 164.79 | 164.79 | 97.09 | 41.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 183.88 | -232.5 | -84.93 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
-17.75 | $ 16.71 | -0.83 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 16.22 | 2.97 % | $ 175 M |  China |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-293.94 | $ 1.57 | -3.4 % | $ 2 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
1.9 | $ 38.53 | -0.26 % | $ 1.07 B | USA |
 |
DarioHealth Corp.
DRIO
|
-66.97 | $ 11.99 | 0.84 % | $ 340 M | Israel |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
28.89 | $ 66.15 | -1.22 % | $ 25.5 B | USA |
 |
Danaher Corporation
DHR
|
9.82 | $ 226.11 | -0.17 % | $ 165 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-36.48 | $ 101.52 | 0.01 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 26.92 | -0.81 % | $ 814 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-77.82 | $ 19.95 | -2.97 % | $ 1.07 B | USA |
 |
Celcuity
CELC
|
-97.97 | $ 101.73 | -3.34 % | $ 4.01 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
-69.16 | $ 3.29 | -8.24 % | $ 105 K | USA |
 |
Co-Diagnostics
CODX
|
-47.68 | $ 0.31 | -9.7 % | $ 9.1 M | USA |
 |
IQVIA Holdings
IQV
|
36.29 | $ 221.67 | -0.25 % | $ 40.2 B | USA |
 |
Guardant Health
GH
|
317.65 | $ 103.94 | 1.83 % | $ 12.8 B | USA |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 133.75 | -0.83 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
6.57 | $ 196.94 | 2.05 % | $ 10.1 B | USA |
 |
Quotient Limited
QTNT
|
232.42 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
19.86 | $ 183.42 | 0.5 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
-41.6 | $ 7.63 | -2.8 % | $ 989 M | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 405.95 | 0.86 % | $ 29.8 B | Schweiz |
 |
Myriad Genetics
MYGN
|
-17.62 | $ 6.96 | -3.47 % | $ 631 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
13.5 | $ 261.21 | -1.12 % | $ 21.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 181.89 | -2.51 % | $ 15 B |  Irlanda |
 |
NeoGenomics
NEO
|
-6.89 | $ 11.99 | 1.14 % | $ 1.52 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 6.78 | -1.16 % | $ 1.47 B | USA |
 |
IDEXX Laboratories
IDXX
|
50.7 | $ 698.37 | -0.83 % | $ 57.6 B | USA |
 |
Lantheus Holdings
LNTH
|
42.0 | $ 67.15 | 0.79 % | $ 4.65 B | USA |
 |
Agilent Technologies
A
|
25.0 | $ 139.73 | 0.05 % | $ 42.5 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.43 | -4.8 % | $ 5.58 M | USA |
 |
Bioventus
BVS
|
-47.08 | $ 7.53 | -0.26 % | $ 472 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | Israel |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Pacific Biosciences of California
PACB
|
-47.69 | $ 2.1 | -1.18 % | $ 533 M | USA |